Given that previous work has shown that HDAC9 can down-regulate miR-376a and thereby promote cancer (55), future studies should identify genes, miRNAs and ncRNAs targeted by HDAC9 in drug-resistant HCC. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.